Csaba Szabo

Dikutip oleh

	Semua	Sejak 2020
Kutipan	90692	21607
indeks-h	152	69
indeks-i10	699	365

4600

2300

1150

3450

1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025297 479 833 1268 1465 1666 1800 2448 2329 2704 3299 3011 3336 3252 3398 3324 3469 3785 3815 3791 3802 3747 3602 3761 3612 3910 4473 4513 4223 3740 742

Akses publik

Lihat semua

205 artikel

15 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Pal PacherNational Institutes of Health, BethesdaEmail yang diverifikasi di mail.nih.gov
Laszlo ViragProfessor of Medical Chemistry, University of Debrecen, Faculty of Medicine, HungaryEmail yang diverifikasi di med.unideb.hu
Jon MableyUniversity of BrightonEmail yang diverifikasi di brighton.ac.uk
george haskoColumbia UniversityEmail yang diverifikasi di cumc.columbia.edu
Andreas PapapetropoulosNational and Kapodistrian University of AthensEmail yang diverifikasi di pharm.uoa.gr
Basilia ZingarelliCincinnati Children’s Hospital Medical CenterEmail yang diverifikasi di cchmc.org
Katalin ModisAssociate ProfessorEmail yang diverifikasi di utmb.edu
Francisco Garcia SorianoProfessor Associado, Departamento de Clínica Médica da Faculdade de Medicina da Universidade de SãoEmail yang diverifikasi di usp.br
Domokos Gero MD, PhDUniversity of Exeter Medical SchoolEmail yang diverifikasi di exeter.ac.uk
Bartosz SzczesnyAssociate ProfessorEmail yang diverifikasi di utmb.edu
Christoph ThiemermannCentre Lead for Translational Medicine & Therapeutics, Queen Mary University of LondonEmail yang diverifikasi di qmul.ac.uk
Salvatore CuzzocreaProfessore di Farmacologia Università di MessinaEmail yang diverifikasi di unime.it
E. Sylvester Vizi MD, PhD, MHAS, Ho...Hun-Ren Inst. of Experimental Medicine, and Semmelweis University, Department of Pharmacology andEmail yang diverifikasi di koki.hu
Anita MartonUniversity of FribourgEmail yang diverifikasi di unifr.ch
Gabor SzaboUniversity of HeidelbergEmail yang diverifikasi di urz.uni-heidelberg.de
Mark R. HellmichProfessor, Department of Surgery, University of Texas Medical BranchEmail yang diverifikasi di utmb.edu
Kanneganti MurthyAkkadian TherapeuticsEmail yang diverifikasi di akkadiantx.com
Wang, RuiYork University, Laurentian U, Lakehead U, U Saskatchewan, U de Montreal, U of AlbertaEmail yang diverifikasi di yorku.ca
Pál GergelyProfessor of Medical Chemistry, University of DebrecenEmail yang diverifikasi di unideb.hu
Perretti MauroWilliam Harvey Research Institute, Barts Medical SchoolEmail yang diverifikasi di qmul.ac.uk

Ikuti

Csaba Szabo

Professor, Chair of Pharmacology, University of Fribourg, Switzerland

Email yang diverifikasi di unifr.ch - Beranda

pharmacology nitric oxide hydrogen sulfide PARP mitochondria


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics C Szabó, H Ischiropoulos, R Radi Nature reviews Drug discovery 6 (8), 662-680, 2007	2452	2007
Hydrogen sulphide and its therapeutic potential C Szabó Nature reviews Drug discovery 6 (11), 917-935, 2007	2215	2007
The therapeutic potential of poly (ADP-ribose) polymerase inhibitors L Virág, C Szabó Pharmacological reviews 54 (3), 375-429, 2002	1855	2002
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol PAL Pacher, A Nivorozhkin, C Szabó Pharmacological reviews 58 (1), 87-114, 2006	1581	2006
Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function JW Elrod, JW Calvert, J Morrison, JE Doeller, DW Kraus, L Tao, X Jiao, ... Proceedings of the National Academy of Sciences 104 (39), 15560-15565, 2007	1384	2007
Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells X Du, T Matsumura, D Edelstein, L Rossetti, Z Zsengellér, C Szabó, ... The Journal of clinical investigation 112 (7), 1049-1057, 2003	1131	2003
Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors P Jagtap, C Szabó Nature reviews Drug discovery 4 (5), 421-440, 2005	1102	2005
Hydrogen sulfide is an endogenous stimulator of angiogenesis A Papapetropoulos, A Pyriochou, Z Altaany, G Yang, A Marazioti, Z Zhou, ... Proceedings of the National Academy of Sciences 106 (51), 21972-21977, 2009	986	2009
Role of poly (ADP-ribose) synthetase in inflammation and ischaemia–reperfusion C Szabó, VL Dawson Trends in pharmacological sciences 19 (7), 287-298, 1998	870	1998
Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation F Garcia Soriano, L Virag, P Jagtap, É Szabó, JG Mabley, L Liaudet, ... Nature medicine 7 (1), 108-113, 2001	815	2001
DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed … C Szabó, B Zingarelli, M O'Connor, AL SALzMAN Proceedings of the National Academy of Sciences 93 (5), 1753-1758, 1996	811	1996
Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer C Szabo, C Coletta, C Chao, K Módis, B Szczesny, A Papapetropoulos, ... Proceedings of the National Academy of Sciences 110 (30), 12474-12479, 2013	780	2013
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms GJ Southan, C Szabó Biochemical pharmacology 51 (4), 383-394, 1996	763	1996
Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation C Coletta, A Papapetropoulos, K Erdelyi, G Olah, K Módis, P Panopoulos, ... Proceedings of the National Academy of Sciences 109 (23), 9161-9166, 2012	753	2012
Multiple pathways of peroxynitrite cytotoxicity C Szabo Toxicology letters 140, 105-112, 2003	704	2003
Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention L Virág, É Szabó, P Gergely, C Szabó Toxicology letters 140, 113-124, 2003	658	2003
Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. G Hasko, C Szabó, ZH Németh, V Kvetan, SM Pastores, ES Vizi Journal of immunology (Baltimore, Md.: 1950) 157 (10), 4634-4640, 1996	649	1996
Gasotransmitters in cancer: from pathophysiology to experimental therapy C Szabo Nature reviews Drug discovery 15 (3), 185-203, 2016	636	2016
Adenosine inhibits IL‐12 and TNF‐α production via adenosine A_2a receptor‐dependent and independent mechanisms G Haskó, DG Kuhel, JF Chen, MA Schwarzschild, EA Deitch, JG Mabley, ... The FASEB Journal 14 (13), 2065-2074, 2000	613	2000
The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury C Szabó Shock 6 (2), 79-88, 1996	596	1996

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama